Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › quadrivalent HPV vaccine

quadrivalent HPV vaccine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of quadrivalent HPV vaccine

3 trials tracked of quadrivalent HPV vaccine: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 146 citations.

3Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 1
  1. Phase 3 Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women Completed · 146 cited
  2. Phase 3 Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts Completed
  3. Phase 2 Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Papilloguard with AS04 shows non-inferior immunogenicity to Gardasil in HPV vaccine trial
Infectious Disease RCT
Papilloguard with AS04 shows non-inferior immunogenicity to Gardasil in HPV vaccine trial Trial Shows Papilloguard Vaccine Provides Strong Protection Against HPV Infection
This Phase III RCT in 670 healthy individuals aged 15-25 years found that Papilloguard (quadrivalent HPV vaccine with AS04) was non-inferior…
A new trial shows the Papilloguard vaccine provides strong antibody levels against four types of HPV, similar to current standard treatments…
Aug 13, 2026